GENIX | VIMSX | GENIX / VIMSX | |
Total Expense Ratio | 1.50 | 0.17 | 882% |
Annual Report Gross Expense Ratio | 1.75 | 0.17 | 1,029% |
Fund Existence | 12 years | 27 years | - |
Gain YTD | 17.071 | 12.042 | 142% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 100000 | 3000 | 3,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 393M | 201B | 0% |
Annual Yield % from dividends | 0.00 | 1.36 | - |
Returns for 1 year | -3.53 | 13.10 | -27% |
Returns for 3 years | 42.56 | 54.69 | 78% |
Returns for 5 years | 40.01 | 61.47 | 65% |
Returns for 10 years | 24.92 | 145.68 | 17% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MIQPX | 12.27 | N/A | N/A |
Morgan Stanley Inst International Eq R6 | |||
HADUX | 79.56 | N/A | N/A |
Horizon Equity Premium Income Advisor | |||
GCICX | 17.71 | N/A | N/A |
Goldman Sachs Intl Eq Insghts C | |||
CVMRX | 22.55 | N/A | N/A |
Calvert Emerging Markets Equity R6 | |||
RLBCX | 38.68 | -0.09 | -0.23% |
American Funds American Balanced R3 |